Emerging evidence suggests that persistent fibrosis in SSc may be driven by endogenous Toll receptor 4 (TLR4) activators, such as tenascin-C, which is elevated in SSc tissues and promotes collagen production via TLR4 signaling. The gene discussed is TLR4; the disease is systemic sclerosis.